Arrowhead Pharmaceuticals Inc. buy Chardan Capital
Start price
10.05.24
/
50%
€20.70
Target price
10.05.25
€55.70
Performance (%)
2.22%
Price
31.05.24
€21.16
Summary
This prediction is currently active. With a performance of 2.22%, the BUY prediction by Chardan_Capital for Arrowhead Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 10.05.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Arrowhead Pharmaceuticals Inc. | -7.759% |
iShares Core DAX® | -0.552% |
iShares Nasdaq 100 | -1.415% |
iShares Nikkei 225® | -0.877% |
iShares S&P 500 | -0.415% |
Comments by Chardan_Capital for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $60.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Chardan_Capital for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.73
08.08.24
08.08.24
-15.60%
31.05.24
31.05.24